IL17A and relapsing-remitting multiple sclerosis: The increased concentration of IFN-γ, IL-12, IL-17, TGFβ -1 and TGFβ-3 in serum is accompanied by the low expression of PD-1 on CD4+ and CD8+ T cells in the blood of RRMS patients.